News
Analyzing DNA methylation patterns in leukemic cells is helping doctors better assess risk and tailor treatments, making ...
Asia sees rising COVID cases due to new variants, low booster uptake, and increased travel; vigilance and boosters remain ...
Acute stress impairs executive functions like memory and inhibition in depression, anxiety, and BPD, possibly explaining poor ...
VITAL trial shows that 2000 IU/day of vitamin D3 significantly reduces telomere shortening, offering promising anti-aging and ...
Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...
PPARγ-targeting diabetes drug pioglitazone shows promise in reducing prostate cancer relapse risk, reveals new research.
Stanford's CRISPR-TO tech enables precise RNA delivery in neurons, offering breakthrough treatment potential for ALS, spinal injuries, and neurodegenerative diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results